Related Experiment Videos
Efficacy studies on a canarypox-rabies recombinant virus
J Taylor1, C Trimarchi, R Weinberg
1Virogenetics Corporation, Troy, New York 12180.
Vaccine
|March 1, 1991
Summary
New canarypox-rabies recombinant viruses offer rabies protection. This study compares their efficacy against other pox-rabies recombinants, advancing rabies vaccine development.
Area of Science:
- Veterinary Virology
- Vaccinology
- Molecular Biology
Background:
- Recombinant avipox viruses expressing the rabies glycoprotein gene have been developed as potential vaccines.
- A fowlpox-rabies recombinant demonstrated protection against rabies virus challenge in non-avian species.
Purpose of the Study:
- To develop a canarypox-rabies recombinant virus.
- To compare the protective efficacy of this new recombinant with existing pox-rabies recombinants.
Main Methods:
- Development of a canarypox virus vector expressing the rabies glycoprotein gene.
- In vivo challenge studies to assess the protective efficacy of the recombinant vaccine.
Main Results:
- Successful development of a canarypox-rabies recombinant.
- Comparative analysis of protective efficacy against rabies virus challenge.
Conclusions:
- The canarypox-rabies recombinant shows promise as a rabies vaccine candidate.
- Further research is warranted to evaluate its efficacy in target species.